248 related articles for article (PubMed ID: 11233795)
21. Immunotherapy of chronic lymphocytic leukemia.
Wierda WG; O'Brien S
Expert Rev Anticancer Ther; 2001 Jun; 1(1):73-83. PubMed ID: 12113136
[TBL] [Abstract][Full Text] [Related]
22. Cancer immunotherapy.
Schuster M; Nechansky A; Kircheis R
Biotechnol J; 2006 Feb; 1(2):138-47. PubMed ID: 16892244
[TBL] [Abstract][Full Text] [Related]
23. Vaccine therapy for non-Hodgkin's lymphoma and other B-cell malignancies.
Leitch HA; Connors JM
Curr Opin Investig Drugs; 2005 Jun; 6(6):597-604. PubMed ID: 15988911
[TBL] [Abstract][Full Text] [Related]
24. Adoptive immunotherapy of cancer: accomplishments and prospects.
Rosenberg SA
Cancer Treat Rep; 1984 Jan; 68(1):233-55. PubMed ID: 6362866
[TBL] [Abstract][Full Text] [Related]
25. Current status and future applications of cellular therapies for cancer.
Copier J; Bodman-Smith M; Dalgleish A
Immunotherapy; 2011 Apr; 3(4):507-16. PubMed ID: 21463192
[TBL] [Abstract][Full Text] [Related]
26. Immunotherapy of hematological malignancies using dendritic cells.
Van de Velde AL; Berneman ZN; Van Tendeloo VF
Bull Cancer; 2008 Mar; 95(3):320-6. PubMed ID: 18390412
[TBL] [Abstract][Full Text] [Related]
27. [Immunotherapy of tumors: from the first experimental studies to the recent clinical applications. I. Passive immunotherapy].
Burrai I; Di Lallo A
Minerva Med; 1991 Sep; 82(9):519-28. PubMed ID: 1944999
[TBL] [Abstract][Full Text] [Related]
28. Novel approaches to the immunotherapy of B-cell malignancies: An update.
Brentjens RJ
Curr Hematol Malig Rep; 2006 Dec; 1(4):258-63. PubMed ID: 20425321
[TBL] [Abstract][Full Text] [Related]
29. Chemo-immunotherapy of colorectal carcinoma: preclinical rationale and clinical experience.
Correale P; Cusi MG; Micheli L; Nencini C; Del Vecchio MT; Torino F; Aquino A; Bonmassar E; Francini G; Giorgi G
Invest New Drugs; 2006 Mar; 24(2):99-110. PubMed ID: 16502353
[TBL] [Abstract][Full Text] [Related]
30. Passive, adoptive, and active immunotherapy: a review of clinical trials in cancer.
Mathé G
Cancer Detect Prev Suppl; 1987; 1():279-90. PubMed ID: 3319146
[TBL] [Abstract][Full Text] [Related]
31. Breast cancer immunotherapy: monoclonal antibodies and peptide-based vaccines.
Mohit E; Hashemi A; Allahyari M
Expert Rev Clin Immunol; 2014 Jul; 10(7):927-61. PubMed ID: 24867051
[TBL] [Abstract][Full Text] [Related]
32. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D
Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
[TBL] [Abstract][Full Text] [Related]
33. Synergistic effect of dendritic cell vaccination and anti-CD20 antibody treatment in the therapy of murine lymphoma.
Gadri Z; Kukulansky T; Bar-Or E; Haimovich J; Hollander N
J Immunother; 2009 May; 32(4):333-40. PubMed ID: 19342972
[TBL] [Abstract][Full Text] [Related]
34. The immunotherapy era of myeloma: monoclonal antibodies, vaccines, and adoptive T-cell therapies.
Hoyos V; Borrello I
Blood; 2016 Sep; 128(13):1679-87. PubMed ID: 27506540
[TBL] [Abstract][Full Text] [Related]
35. [Immunotherapy: new insights].
Geissler M; Weth R
Praxis (Bern 1994); 2002 Dec; 91(51-52):2236-46. PubMed ID: 12564040
[TBL] [Abstract][Full Text] [Related]
36. Monoclonal antibodies in cancer immunotherapy.
Kimiz-Gebologlu I; Gulce-Iz S; Biray-Avci C
Mol Biol Rep; 2018 Dec; 45(6):2935-2940. PubMed ID: 30311129
[TBL] [Abstract][Full Text] [Related]
37. Immunotherapy as an adjuvant therapy in the management of advanced, surgically resected, melanoma.
Kalani AD; Jack A; Montenegro G; Degliuomini J; Wallack MK
G Ital Dermatol Venereol; 2008 Feb; 143(1):59-70. PubMed ID: 18833052
[TBL] [Abstract][Full Text] [Related]
38. Immunotherapy in children: report from the Reisensburg-Symposium October 20-22, 2004 and recent advances.
Klingebiel T; Bader P; Hollatz G; Koehl U; Lehrnbecher T; Meisel R; Dilloo D
Klin Padiatr; 2006; 218(6):355-65. PubMed ID: 17080339
[TBL] [Abstract][Full Text] [Related]
39. Immunotherapy strategies in the treatment of breast cancer.
Soliman H
Cancer Control; 2013 Jan; 20(1):17-21. PubMed ID: 23302903
[TBL] [Abstract][Full Text] [Related]
40. Biologic therapy for lymphoma.
Bendandi M; Longo DL
Curr Opin Oncol; 1999 Sep; 11(5):343-50. PubMed ID: 10505770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
